These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 15921805

  • 1. Effects of nebivolol on left ventricular function in elderly patients with chronic heart failure: results of the ENECA study.
    Edes I, Gasior Z, Wita K.
    Eur J Heart Fail; 2005 Jun; 7(4):631-9. PubMed ID: 15921805
    [Abstract] [Full Text] [Related]

  • 2. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
    Wolf SC, Buck-Müller N, Görner S, Risler T, Brehm BR.
    Med Klin (Munich); 2003 Jan 15; 98(1):1-6. PubMed ID: 12540987
    [Abstract] [Full Text] [Related]

  • 3. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
    van Veldhuisen DJ, Cohen-Solal A, Böhm M, Anker SD, Babalis D, Roughton M, Coats AJ, Poole-Wilson PA, Flather MD, SENIORS Investigators.
    J Am Coll Cardiol; 2009 Jun 09; 53(23):2150-8. PubMed ID: 19497441
    [Abstract] [Full Text] [Related]

  • 4. Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study.
    Conraads VM, Metra M, Kamp O, De Keulenaer GW, Pieske B, Zamorano J, Vardas PE, Böhm M, Dei Cas L.
    Eur J Heart Fail; 2012 Feb 09; 14(2):219-25. PubMed ID: 22147202
    [Abstract] [Full Text] [Related]

  • 5. Nebivolol for heart failure in the elderly.
    Tavazzi L.
    Expert Rev Cardiovasc Ther; 2007 May 09; 5(3):423-33. PubMed ID: 17489667
    [Abstract] [Full Text] [Related]

  • 6. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
    Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, Böhm M, Anker SD, Thompson SG, Poole-Wilson PA, SENIORS Investigators.
    Eur Heart J; 2005 Feb 09; 26(3):215-25. PubMed ID: 15642700
    [Abstract] [Full Text] [Related]

  • 7. [Optimization of use of beta-adrenoblockers in the treatment of chronic heart failure in the outpatient setting].
    Zhubrina ES, Ovchinnikov AG, Seredenina EM, Patrusheva IF, Blankova ZN, Kuz'mina AE, Kheĭmets GI, Ageev FT.
    Ter Arkh; 2009 Feb 09; 81(11):35-40. PubMed ID: 20141011
    [Abstract] [Full Text] [Related]

  • 8. Effect of nebivolol on left ventricular function in patients with chronic heart failure: a pilot study.
    Brehm BR, Wolf SC, Görner S, Buck-Müller N, Risler T.
    Eur J Heart Fail; 2002 Dec 09; 4(6):757-63. PubMed ID: 12453547
    [Abstract] [Full Text] [Related]

  • 9. ENOS is not activated by nebivolol in human failing myocardium.
    Brixius K, Song Q, Malick A, Boelck B, Addicks K, Bloch W, Mehlhorn U, Schwinger RH.
    Life Sci; 2006 Aug 22; 79(13):1234-41. PubMed ID: 16716362
    [Abstract] [Full Text] [Related]

  • 10. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
    Kobayashi M, Machida N, Mitsuishi M, Yamane Y.
    Am J Hypertens; 2004 Dec 22; 17(12 Pt 1):1112-9. PubMed ID: 15607617
    [Abstract] [Full Text] [Related]

  • 11. [Elderly heart failure patients and the role of beta-blocker therapy].
    Middeljans-Tijssen CW, Jansen RW.
    Tijdschr Gerontol Geriatr; 2006 Apr 22; 37(2):67-77. PubMed ID: 16704019
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure.
    Del Sindaco D, Tinti MD, Monzo L, Pulignano G.
    Clin Interv Aging; 2010 Dec 03; 5():381-93. PubMed ID: 21152240
    [Abstract] [Full Text] [Related]

  • 16. [Initial data on nebivolol in heart failure. Beta blockers strengthen older hearts, too].
    MMW Fortschr Med; 2003 May 29; 145(22):55. PubMed ID: 12866284
    [No Abstract] [Full Text] [Related]

  • 17. Nebivolol: a third-generation beta-adrenergic blocker.
    Veverka A, Nuzum DS, Jolly JL.
    Ann Pharmacother; 2006 May 29; 40(7-8):1353-60. PubMed ID: 16822893
    [Abstract] [Full Text] [Related]

  • 18. Comparative cardiac haemodynamics of bisoprolol, celiprolol, carvedilol and nebivolol in normal volunteers.
    De Cree J, Van Nueten L, Geukens H, Verhaegen H.
    Int J Clin Pharmacol Res; 1992 May 29; 12(4):159-63. PubMed ID: 1363660
    [Abstract] [Full Text] [Related]

  • 19. [Role of the L-arginine/nitric oxide system in the action of nebivolol].
    Brodde OE, Philipp T.
    Dtsch Med Wochenschr; 2006 Nov 10; 131(45):2545-50. PubMed ID: 17091442
    [Abstract] [Full Text] [Related]

  • 20. Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS]).
    de Boer RA, Doehner W, van der Horst IC, Anker SD, Babalis D, Roughton M, Coats AJ, Flather MD, van Veldhuisen DJ, SENIORS Investigators.
    Am J Cardiol; 2010 Jul 01; 106(1):78-86.e1. PubMed ID: 20609652
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.